Cancer biomarkers can significantly aid in the early diagnosis of cancer. For instance, the presence of the protein Prostate-Specific Antigen (PSA) in blood is used for screening prostate cancer. Similarly, elevated levels of CA-125 can indicate ovarian cancer. The identification of these biomarkers helps in the early detection and intervention, potentially improving patient outcomes.
